These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16130895)

  • 1. Tumor angiogenesis and molecular target therapy in ovarian carcinomas.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Futakuchi H; Yamaguchi H; Yasuda M; Nishiyama K; Ueki M
    Hum Cell; 2005 Mar; 18(1):1-16. PubMed ID: 16130895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for suppressing angiogenesis in gynecological cancers.
    Ma WW; Jimeno A
    Drugs Today (Barc); 2007 Apr; 43(4):259-73. PubMed ID: 17460787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.
    Yoneda J; Kuniyasu H; Crispens MA; Price JE; Bucana CD; Fidler IJ
    J Natl Cancer Inst; 1998 Mar; 90(6):447-54. PubMed ID: 9521169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer.
    Loizzi V; Del Vecchio V; Gargano G; De Liso M; Kardashi A; Naglieri E; Resta L; Cicinelli E; Cormio G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28906427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis as a strategic target for ovarian cancer therapy.
    Spannuth WA; Sood AK; Coleman RL
    Nat Clin Pract Oncol; 2008 Apr; 5(4):194-204. PubMed ID: 18268546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic therapy in ovarian cancer: a great expectation to be confirmed.
    González Martín A
    Clin Transl Oncol; 2009 Sep; 11(9):559-60. PubMed ID: 19775993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peritoneal dissemination of ovarian cancer and tumor angiogenesis].
    Baba T; Mandai M; Fujii S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():467-70. PubMed ID: 15535289
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis and ovarian cancer.
    Gómez-Raposo C; Mendiola M; Barriuso J; Casado E; Hardisson D; Redondo A
    Clin Transl Oncol; 2009 Sep; 11(9):564-71. PubMed ID: 19775995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
    Cao Y; Liu Q
    Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
    Al Wadi K; Ghatage P
    Expert Opin Pharmacother; 2016; 17(6):853-60. PubMed ID: 26933765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bevacizumab: progress in the treatment of metastatic cancer and hope for patients with proliferative retinopathy].
    Antoniak K; Nowak JZ
    Postepy Hig Med Dosw (Online); 2007 May; 61():320-30. PubMed ID: 17554235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
    Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition.
    Martin L; Schilder R
    J Clin Oncol; 2007 Jul; 25(20):2894-901. PubMed ID: 17617520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.
    Sánchez-Muñoz A; Pérez-Ruiz E; Mendiola Fernández C; Alba Conejo E; González-Martín A
    Clin Transl Oncol; 2009 Sep; 11(9):589-95. PubMed ID: 19775998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor inhibitors in colon cancer.
    Díaz-Rubio E
    Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer.
    Collins TS; Hurwitz HI
    Semin Oncol; 2005 Feb; 32(1):61-8. PubMed ID: 15726507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New medications; bevacizumab].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in epithelian ovarian cancer.
    Bamberger ES; Perrett CW
    Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.